Firms team up to develop peptide-based eye treatments

09/9/2013 | PharmaTimes (U.K.)

ThromboGenics and Bicycle Therapeutics agreed to collaborate in the development of treatments for diabetic macular edema and other eye conditions using the latter's bicyclic peptides. The deal entitles Bicycle to an upfront payment, milestone fees and sales royalties.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR